NDC 65174-200-01 - Drax Exametazime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65174-200
- Requested NDC
- 65174-200-01
- Package NDCs from labels
- 65174-200-01, 65174-200-05
- Manufacturer
- Jubilant DraxImage Inc., dba Jubilant Radiopharma | Jubilant HollisterStier General Partnership
- Effective date
- 2024-12-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drax Exametazime - Jubilant DraxImage Inc., dba Jubilant Radiopharma | Jubilant HollisterStier General Partnership | Jubilant DraxImage Inc., dba Jubilant Radiopharma | Jubilant HollisterStier General Partnership | 2024-12-02 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65174-200-01 | Drax Exametazime | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | 4 | |
| 65174-200-05 | Drax Exametazime | 5 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 5 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65174-200 | DRAX EXAMETAZIME (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M EXAMETAZIME FOR LEUKOCYTE LABELING) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [JUBILANT DRAXIMAGE INC., DBA JUBILANT RADIOPHARMA] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241208_fa7811f9-2803-4126-8037-8f3e56462f9c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65174-200-01 | EA - Each | 65174-200 | 8741bff3-075f-4f11-a1d4-709c8768efc3 | 1 | 2024-04-05 |
| 65174-200-05 | EA - Each | 65174-200 | 3883d260-f601-404a-8a5f-a584bff0612f | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitrogen | NITROGEN | MITCHELL WELDING SUPPLY DBA Meritus Texas | fa2df808-fd08-c1e8-e053-6294a90a7719 | 2026-03-24 | N762921K75 | |
| Nitrogen | NITROGEN | Roadrunner Oxygen Service, Inc. | 43cf50cf-e02d-4dd9-aac2-c765b504262b | 2026-03-24 | N762921K75 | |
| Reflux Away | ABIES NIGRA, ANTIMONIUM CRUDUM, ARGENTUM NITRICUM, CARBO VEGETABILIS, CHELIDONIUM MAJUS, COLOCYNTHIS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA | NaturalCare | 8a00a72f-60df-4477-b7b8-abb6355e34da | 2026-03-24 | Warnings | 451W47IQ8X |
| Worafy Gentle Eye Wash | SODIUM CHLORIDE | Shenzhen Shandian Jingling Technology Co., Ltd. | 4da864dc-e10c-1db9-e063-6394a90a0984 | 2026-03-22 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE HYPERTONICITY | SODIUM CHLORIDE | YYBA CORP | 439653b9-99b8-4799-8d67-4a2ada9c6783 | 2026-03-20 | Warnings | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | e13fd053-9420-490c-a43e-e14b0930cb4e | 2026-03-18 | Warnings | 451W47IQ8X |
| Universaltox | ALFALFA, AVENA SATIVA, FUCUS VESICULOSUS, HORDEUM VULGARE, NASTURTIUM AQUATICUM, RAPHANUS SATIVUS, TRITICUM AESTIVUM, IODIUM, UBIDECARENONUM, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, MANGANESE GLUCONATE, ORYZA SATIVA, THYROIDINUM (SUIS), CALCAREA CARBONICA, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), RHUS TOX, CORTISONE ACETICUM | BioActive Nutritional, Inc. | ad454e8a-4f78-4aac-90d9-a3f26a6fbe42 | 2026-03-17 | Warnings | 451W47IQ8X |
| BM BIO27 | CALC PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d229815-05f4-27c5-e063-6394a90ac865 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO1 | CALC PHOS, FERR PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d265d99-fdbb-5efb-e063-6394a90a89ac | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO16 | CALC PHOS, FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d26b4a9-ee27-6915-e063-6294a90a5d4d | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO12 | FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d2747ad-958e-63a1-e063-6294a90aea66 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b812c9-fb0a-5ee0-e063-6294a90a03e1 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b88e7c-eca0-5540-e063-6294a90a1b18 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b8c3f4-e528-c69d-e063-6294a90a5a34 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b7eb13-39c3-6f0e-e063-6394a90a4011 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8bb9c-d30f-152f-e063-6394a90a5208 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8dcbd-9e6b-1edc-e063-6394a90aac73 | 2026-03-16 | Warnings | 451W47IQ8X |
| Nitrogen | NITROGEN | Machine & Welding Supply Company dba Arc3 Gases South | 2f752307-56a0-41e1-82e0-da3c9680faec | 2026-03-16 | N762921K75 | |
| BM BIO20 | CALC FLUOR, CALC SULF, KALI SULF, NAT MUR, NAT SULF | BM Private Limited | 4d285396-9df8-86bc-e063-6294a90ad4de | 2026-03-16 | Warnings | 451W47IQ8X |
| HZ HP | LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NITRICUM ACIDUM, RANUNCULUS BULBOSUS, RHUS TOX, SEPIA, THUJA OCCIDENTALIS | BioActive Nutritional, Inc. | b662dea8-4eb5-4c80-a5ab-7d3688732773 | 2026-03-13 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.